Changes in IGF activities in human diabetic vitreous

Diabetes

Volumn 53, Issue 9, 2004, Pages 2428-2435

  Guidry, Clyde ^a   Feist, Richard ^a   Morris, Robert ^a   Hardwick, Charles W ^a  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; SOMATOMEDIN C;

ADULT; AGE; AGED; ANIMAL CELL; ARTICLE; BIOASSAY; BIOCHEMISTRY; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DIABETIC VITREOUS; DOSE RESPONSE; EXTRACELLULAR MATRIX; FEMALE; FIBROVASCULAR SCAR; FORCE; GENDER; GLIA; HUMAN; HUMAN TISSUE; MALE; MUELLER CELL; NONHUMAN; PRIORITY JOURNAL; RETINA DETACHMENT; SCAR; TRACTION FORCE; VITREOUS BODY; VITREOUS HEMORRHAGE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; ANTIBODIES, MONOCLONAL; CELLS, CULTURED; DIABETIC RETINOPATHY; EXTRACELLULAR MATRIX; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MALE; MIDDLE AGED; NEUROGLIA; PLATELET-DERIVED GROWTH FACTOR; RETINA; SWINE; VITREOUS BODY;

EID: 4344650398     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.53.9.2428     Document Type: Article

References (47)

1. Davis M: Diabetic retinopathy: a clinical overview. Diabetes Care 15:1844-1874, 1992
2. Aiello LP, Gardner TW, King GL, Blankenship G, Cavallerano JD, Ferris FL 3rd, Klein R: Diabetic retinopathy. Diabetes Care 21:143-156, 1998
3. Neely K, Quillen D, Schahat A, Gardner T, Blankenship G: Diabetic retinopathy. Med Clin North Am 82:847-876, 1998
4. Tzekov R, Arder GB: The electroretinogram in diabetic retinopathy. Surv Opthalmol 44:53-60, 1999
5. Li Q, Zemel E, Miller B, Perlman I: Early retinal damage in experimental diabetes: electroretinographical and morphological observations. Exp Eye Res 74:615-625, 2002
6. Li Q, Puro DG: Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Invest Ophthalmol Vis Sci 43:3109-3116, 2002
7. Mizutani M, Gerhardinger C, Lorenzi M: Müller cell changes in human diabetic retinopathy. Diabetes 47:445-449, 1998
8. Rungger-Brandle E, Dosso AA, Leuenberger PM: Glial reactivity, an early feature of diabetic retinopathy. Invest Ophthalmol Vis Sci 41:1971-1980, 2000
9. Leith W, Barber AJ, Xu B, Dice C, Ratz MJ, Tanase D, Strother JM: Glial reactivity and impaired glutamate metabolism in short-term experimental diabetic retinopathy. Diabetes 47:815-820, 1998
10. Abu El-Asrar AM, Desmet S, Meersschaert A, Dralands L, Missotten L, Geboes K: Expression of the inducible isoform of nitric oxide synthase in the retinas of human subjects with diabetes mellitus. Am J Ophthalmol 132:551-556, 2001
11. Vinores SA, Youssri Al, Luna JD, Chen YS, Bhargave S, Vinores MA, Schoenfeld CL, Peng B, Chan CC, LaRochelle W, Green WR, Campochiaro PA: Upregulation of vascular endothelial growth factor in ischemic and non-ischemic human and experimental retinal disease. Histol Histopathol 12:99-109, 1997
12. Murata T, Nakagawa K, Khalil A, Ishibashi T, Inomata H, Sueishi K: The relation between expression of vascular endothelial growth factor and breakdown of the blood-retinal barrier in diabetic rat retinas. Lab Invest 74:819-825, 1996
13. Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW: Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Invest Ophthalmol Vis Sci 38:36-47, 1997
14. Nork TM, Wallow IHL, Sramek SJ, Anderson G: Muller's cell involvement in proliferative diabetic retinopathy. Arch Ophthalmol 105:1424-1429, 1987
15. Sramek SJ, Wallow IH, Stevens TS, Nork TM: Immunostaining of preretinal membranes for actin, fibronectin, and glial fibrillary acidic protein. Ophthalmology 96:835-841, 1989
16. Hosoda Y, Okada M, Matsumura M, Ogino N, Honda Y, Nagai Y: Epiretinal membrane of proliferative diabetic retinopathy: an immunohistochemical study. Ophthalmic Res 25:289-294, 1993
17. Guidry C: Isolation and characterization of porcine Muller cells: myofibroblastic dedifferentiation in culture. Invest Ophthalmol Vis Sci 37:740-752, 1996
18. Guidry C: Tractional force generation by porcine Muller cells: development and differential stimulation by growth factors. Invest Ophthalmol Vis Sci 38:456-468, 1997
19. Guidry C, Bradley KM, King JL: Tractional force generation by human Muller cells: growth factor responsiveness and integrin receptor involvement. Invest Ophthalmol Vis Sci 44:1355-1363, 2003
20. Freyberger H, Brocker M, Yakut H, Hammer J, Effert R, Schifferdecker E, Schatz H, Derwahl M: Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy. Exp Clin Endocrinol Diabetes 108:106-109, 2000
21. Boulton M, Gregor Z, McLeod D, Charteris D, Jarvis-Evans J, Moriarty P, Khaliq A, Foreman D, Allamby D, Bardsley B: Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management. Br J Ophthalmol 81:228-233, 1997
22. Burgos R, Mateo C, Canton A, Hernandez C, Mesa J, Simo R: Vitreous levels of IGF-I, IGF binding protein 1, and IGF binding protein 3 in proliferative diabetic retinopathy: a case-control study. Diabetes Care 23:80-83, 2000
23. Grant M, Russel B, Fitzgerald C, Merimee T: Insulin-like growth factors in vitreous: studies in control and diabetic subjects with neovascularization. Diabetes 35:416-420, 1986
24. Inokuchi N, Ikeda T, Imamura Y, Sotozono C, Kinoshita S, Uchihori Y, Nakamura K: Vitreous levels of insulin-like growth factor-I in patients with proliferative diabetic retinopathy. Curr Eye Res 23:368-371, 2001
25. Meyer-Schwickerath R, Pfeiffer A, Blum WF, Freyberger H, Klein M, Losche C, Rollmann R, Schatz H: Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease: studies in nondiabetic and diabetic subjects. J Clin Invest 92:2620-2625, 1993
26. Spranger J, Buhnen J, Jansen V, Krieg M, Meyer-Schwickerath R, Blum WF, Schatz H, Pfeiffer AF: Systemic levels contribute significantly to increased intraocular IGF-I, IGF-II and IGF-BP3 [correction of IFG-BP3] in proliferative diabetic retinopathy. Horm Metab Res 32:196-200, 2000
27. Spranger J, Mohlig M, Osterhoff M, Buhnen J, Blum WF, Pfeiffer AF: Retinal photocoagulation does not influence intraocular levels of IGF-I, IGF-II and IGF-BP3 in proliferative diabetic retinopathy: evidence for combined treatment of PDR with somatostatin analogues and retinal photocoagulation? Horm Metab Res 33:312-316, 2001
28. Hardwick C, Feist R, Morris R, White M, Witherspoon D, Angus R, Guidry C: Tractional force generation by porcine Muller cells: stimulation by growth factors in human vitreous. Invest Ophthalmol Vis Sci 38:2053-2063, 1997
29. Hardwick CW Jr, Morris R, Guidry C: Quantitative vitreous collection using a modified infusion fluid during vitrectomy. Retina 17:51-56, 1997
30. Miller E, Rhodes R: Preparation and characterization of the different types of collagen. Meth Enzymol 82:33-64, 1982
31. Guidry C, Grinnell F: Studies on the mechanism of hydrated collagen gel reorganization by human skin fibroblasts. J Cell Sci 79:67-81, 1985
32. Guidry C, Hook M: Endothelins produced by endothelial cells promote collagen gel contraction by fibroblasts. J Cell Biol 115:873-880, 1991
33. Simo R, Lecube A, Segura RM, Garcia Arumi J, Hernandez C: Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy. Am J Ophthalmol 134:376-382, 2002
34. Conover CA: Regulation and physiological role of insulin-like growth factor binding proteins. Endocrine J 43:S43-S48, 1996
35. Collett-Soberg PR, Cohen P: The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action. Endocrinol Metab Clin North Am 25:591-614, 1996
36. LeRoith D: Insulin-like growth factors. N Engl J Med 336:633-640, 1997
37. Arnold DR, Moshayedi P, Schoen TJ, Jones BE, Chader GJ, Waldbillig RJ: Distribution of IGF-I and -II, IGF binding proteins (IGFBPs) and IGFBP mRNA in ocular fluids and tissues: potential sites of synthesis of IGFBPs in aqueous and vitreous. Exp Eye Res 56:555-565, 1993
38. Pfeiffer A, Spranger J, Meyer-Schwickerath R, Schatz H: Growth factor alterations in advanced diabetic retinopathy: a possible role of blood retina barrier breakdown. Diabetes 46 (Suppl. 2):S26-S30, 1997
39. Waldbillig RJ, Jones BE, Schoen TJ, Moshayedi P, Heidersbach S, Bitar MS, van Kuijk FJ, de Juan E, Kador P, Chader GJ: Vitreal insulin-like growth factor binding proteins (IGFBPs) are increased in human and animal diabetics. Curr Eye Res 13:539-546, 1994
40. Ferry RJ, Katz LEL, Grimberg A, Cohen P, Weinzimer SA: Cellular actions of insulin-like growth factor binding proteins. Horm Met Res 31:192-202, 1998
41. Ferry RJ, Cerri RW, Cohen P: Insulin-like growth factor binding proteins: new proteins, new functions. Horm Res 51:53-67, 1999
42. Baxter RC: Molecular Aspects of Insulin-Like Growth Factor Binding Proteins: Advances in Molecular and Cellular Endocrinology. Vol. 1. Stamford, CT, JAI Press, 1997, p. 123-159
43. Montesano R, Orci L: Transforming growth factor-beta stimulates collagen-matrix contraction by fibroblasts: implication for wound healing. Proc Natl Acad Sci USA 85:4894-4897, 1988
44. Pena R, Jerdan J, Glaser B: Effects of TGF-β and TGF-β neutralizing antibodies on fibroblast-induced collagen gel contraction: implications for proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 35:2804-2808, 1994
45. Liu X, Kohyama T, Wang H, Zhu YK, Wen FQ, Kim HJ, Romberger DJ, Rennard SI: Th2 cytokine regulation of type I collagen gel contraction mediated by human/lung mesenchymal cells. Am J Physiol Lung Cell Mol Physiol 282:L1049-L1056, 2002
46. Panetti TS, Magnusson MK, Peyruchaud O, Zhang Q, Cooke ME, Sakai T, Mosher DF: Modulation of cell interactions with extracellular matrix by lysophosphatidic acid and sphingosine 1-phosphate. Prostaglandins 64:93-106, 2001
47. Grinnell F: Fibroblast-collagen-matrix contraction: growth-factor signaling and mechanical loading. Trends Cell Biol 10:362-365, 2000